Leo Pharma ends Boston bet

A reorganization of the company’s structure has cost the life of Leo Pharma’s Science & Tech Hub, a five-year-old project in Boston, US.
Photo: Sergi Reboredo/SIPA/Ritzau Scanpix
Photo: Sergi Reboredo/SIPA/Ritzau Scanpix
by ANDREAS LØNSTRUP, translated by daniel pedersen

On Wednesday, Leo Pharma announced changes to its global organization, including the layoffs of 68 people with an additional 1,000 positions disappearing over the next two years.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading